Inhibition of HIV-1 RNase H Activity by Nucleotide Dimers and Monomers
| Autor: | S. H. Krawczyk, J. M. Cherrington, N. Bischofberger, S. J. W. Allen, A. S. Mulato, L. R. McGee |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
0301 basic medicine
chemistry.chemical_classification Feline immunodeficiency virus biology RNase P 030106 microbiology General Medicine biology.organism_classification 01 natural sciences Virology Molecular biology Virus Reverse transcriptase 0104 chemical sciences 010404 medicinal & biomolecular chemistry 03 medical and health sciences Enzyme chemistry Enzyme inhibitor biology.protein Nucleotide RNase H |
| Zdroj: | Antiviral Chemistry and Chemotherapy. 7:37-45 |
| ISSN: | 2040-2066 |
| Popis: | Nucleotide dimers and monomers were shown to inhibit human immunodeficiency virus type 1 (HIV) RNase H activity. Several effective inhibitors were identified and placed into three general groups based on biochemical characterization of their inhibition, The first group (group A) inhibited HIV RNase H and the closely related feline immunodeficiency virus (FIV) RNase H, but did not inhibit less related retroviral or cellular RNases H or HIV reverse transcriptase (RT). The second group (group B) inhibited the RNase H activity of several retroviruses as well as the reverse transcriptase function of HIV RT. The third group (group C) inhibited RNases H from retroviral and cellular sources but did not inhibit HIV RT. Kinetic analyses of HIV RNase H inhibition were conducted and all three types of inhibitors exhibited a competitive mode of inhibition with regard to substrate. The small nucleotides described here represent the most potent (Ki values from 0.57 to 16 μM) and selective inhibitors of HIV RNase H reported to date. Further structure - function analyses of these molecules may lead to the discovery of unique, potent antiretroviral therapeutics. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|